InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Kies Peter, 首席财务官. Director active across 2 companies, notably INOVIO PHARMACEUTICALS, INC.. In total, 12 filings have been recorded. Split: 0 buy · 1 sell. Total volume traded: €66k. History available since 3 June 2021. The latest transaction was disclosed on 9 June 2021 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Kies Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报12 总计
5,010 股Common StockSEC:0001259780-26-000002:0
4,771 股Common StockSEC:0001055726-25-000029:0
3,997 股Common StockSEC:0001055726-25-000002:0
4,771 股Common StockSEC:0001055726-24-000031:0
1,878 股Common StockSEC:0001055726-24-000003:0
59,737 股Common StockSEC:0001055726-23-000011:0
22,544 股Common StockSEC:0001055726-23-000005:0
59,737 股Common StockSEC:0001055726-22-000019:0
21,466 股Common StockSEC:0001055726-22-000017:0
22,545 股Common StockSEC:0001055726-22-000012:0
13,750 股@ US$2.1626.9% 占其流量Common StockSEC:0001055726-21-000050:0
10,000 股@ US$8.0373.1% 占其流量Common StockSEC:0001055726-21-000049:0
12 条申报中的 12 条
About Kies Peter
KIES PETER is Directeur Financier at INOVIO PHARMACEUTICALS, INC. and Inovio Pharmaceuticals, INC. The record shows 12 filings in total, and among the recent filings sampled, the period runs from 2021-06-04 to 2026-02-27, with 0 in buys and 66183 in sells, and the most common transaction nature being Levée d'options.
